Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia.

@article{Shahmanesh2005AntiretroviralTR,
  title={Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia.},
  author={Mohsen Shahmanesh and Satyajit Das and Michael Stolinski and Fariba Shojaee-Moradie and Nicola C. Jackson and William Jefferson and Robert Cramb and Peter Nightingale and A. Margot Umpleby},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2005},
  volume={90 2},
  pages={
          755-60
        }
}
  • Mohsen Shahmanesh, Satyajit Das, +6 authors A. Margot Umpleby
  • Published in
    The Journal of clinical…
    2005
  • Medicine
  • The relationship between antiretroviral treatment of HIV infection, body fat distribution, insulin resistance, and very-low-density lipoprotein (VLDL) and intermediate-density lipoprotein (IDL) apolipoprotein-B (apoB) kinetics was investigated in 55 HIV-infected patients taking two nucleoside analogs plus either a protease inhibitor (n = 15) or a nonnucleoside reverse transcriptase inhibitor (n = 25), 15 antiretroviral therapy-naive patients, and 12 HIV-negative controls. Compared with the… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 33 CITATIONS

    Progression of coronary artery disease in a HIV-infected patient previously treated for ascending aorta aneurysm

    Cardiovascular Disease-Risk Markers in HIV Patients

    VIEW 1 EXCERPT
    CITES BACKGROUND

    HIV is an independent predictor of aortic stiffness

    VIEW 1 EXCERPT
    CITES BACKGROUND